Abstract
Background
Children with Henoch-Schönlein purpura nephritis (HSPN) have an increased risk of chronic kidney disease (CKD). Renal biopsy diagnostic of HSPN is graded using the International Study of Kidney Disease in Children criteria, which do not predict outcomes. The 2016 Oxford Classification’s MEST-C scoring system predicts outcomes in adults with histologically identical IgA nephropathy, but evidence of its utility in pediatric HSPN is lacking. Our hypothesis was that MEST-C scores predict outcomes in children with HSPN.
Methods
A retrospective cohort analysis of data from 32 children with HSPN who underwent renal biopsy was performed. We used logistic regression and receiver operator characteristic curves to analyze the ability of MEST-C to predict the composite outcome of hypertension (blood pressure ≥ 95% for age/sex/height), CKD (estimated glomerular filtration rate < 90 mL/min/1.73 m2), or proteinuria (urine protein-to-creatinine ratio > 0.2 mg/mg).
Results
The median age at diagnosis was 7.9 years (IQR 5.8, 11.7); 56% were male, 19% were Hispanic, and 9% were Black. After a median follow-up of 2.7 years, 38% of patients (n = 12) reached the outcome. S1 score was significantly associated with the outcome (OR 7.9, 95% CI 1.5–42.6). S1 accurately predicted the outcome (area under the curve 0.72, 95% CI 0.55–0.88) with 58.3% sensitivity and 85.0% specificity, indicating a positive predictive value of 70.0% and a negative predictive value of 77.3%.
Conclusions
S1 accurately predicted our composite outcome of hypertension, CKD, and proteinuria in a diverse cohort of U.S. children with HSPN. Further investigation is warranted to validate these findings.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- eGFR:
-
Estimated glomerular filtration rate
- CKD:
-
Chronic kidney disease
- HSPN:
-
Henoch-Schönlein purpura nephritis
- IQR:
-
Interquartile range
- ISKDC:
-
The International Study of Kidney Disease in Children
- IgAN:
-
IgA nephropathy
- ROC:
-
Receiver operator characteristics
- UPCR:
-
Urine protein-to-creatinine ratio
References
Davin J, Ten Berge I, Weening J (2001) What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 59:823–834. https://doi.org/10.1046/j.1523-1755.2001.059003823.x
Hahn D, Hodson E, Willis N, Craig J (2015) Interventions for preventing and treating kidney disease in Henoch-Schönlein purpura (HSP). Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005128.pub3
Schärer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F (1999) Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 13:816–823. https://doi.org/10.1007/s004670050707
Chen J, Mao J (2015) Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management. World J Pediatr 11:29–34. https://doi.org/10.1007/s12519-014-0534-5
Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916–920. https://doi.org/10.1136/adc.2005.074641
Davin J (2011) Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol 6:679–689. https://doi.org/10.2215/CJN.06710810
Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L (2006) Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis 47:993–1003. https://doi.org/10.1053/j.ajkd.2006.02.178
Davin J, Coppo R (2013) Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch–Schönlein purpura nephritis. Pediatr Nephrol 28:1897–1903. https://doi.org/10.1007/s00467-013-2550-4
Soylemezoglu O, Ozkaya O, Ozen S, Bakkaloglu A, Dusunel R, Peru H, Donmez O, Buyan N, Mir S, Gur-Guven A, Alpay H, Ekim M, Aksu N, Soylu A, Gok F, Poyrazoglu H, Sonmez F (2009) Henoch-Schonlein nephritis: a nationwide study. Nephron Clin Pract 112:c199–c204. https://doi.org/10.1159/000218109
Foster B, Bernard C, Drummond K, Sharma A (2000) Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375. https://doi.org/10.1067/mpd.2000.103448
Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena F (1997) Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology collaborative study on Henoch-Schönlein purpura. Nephrol Dial Transplant 12:2277–2283
Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet 360:666–670. https://doi.org/10.1016/S0140-6736(02)09835-5
Trimarchi H, Barratt J, Cattran DC, Cook T, Coppo R, Haas M, Liu Z, Roberts I, Yuzawa Y, Zhang H, Feehally J, Alpers C, Asunis A, Barbour S, Becker J, Ding J, Espino G, Ferrario F, Fogo A, Hladunewich M, Joh K, Katafuchi R, Matsuzaki K, Nakanishi K, Pani A, Perera R, Perkowska A, Reich H, Shima Y, Soares M, Suzuki Y, Takahashi K, Troyanov S, Verhave J, Wang S, Weening J, Wyatt R, Yoshikawa N, Zeng C (2017) Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int 91:1014–1021. https://doi.org/10.1016/j.kint.2017.02.003
Roberts I, Cook H, Troyanov S, Alpers C, Amore A, Baratt J, Berthoux F, Bonsib S, Bruijin J, Cattran D, Coppo R, D’Agati V, Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza F, Florquin S, Fogo A, Geddes C, Groene H, Herzenberg A, Hill P, Hogg R, Hsu S, Jennette C, Joh K, Julian B, Kawamura T, Lai F, Li L, Li P, Liu Z, Macjinnon B, Mezzano S, Schena P, Tomino Y, Walker P, Wang H, Weening J, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546–556. https://doi.org/10.1038/ki.2009.168
Magistroni R, D’Agati V, Appel G, Kiryluk K (2015) New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int 88:974–989. https://doi.org/10.1038/ki.2015.252
Jennette J (2006) Immunoglobin A nephropathy and Henoch-Schonlein purpura. In: Fundamentals of renal pathology. Springer, New York, pp 61–69
Xu K, Zhang L, Ding J, Wang S, Su B, Xiao H, Wang F, Zhong X, Ly Y (2018) Value of the Oxford classification of IgA nephropathy in children with Henoch–Schönlein purpura nephritis. J Nephrol 31:279–286. https://doi.org/10.1007/s40620-017-0457-z
Szeto C, Choi P, To K, Li P, Hui J, Chow K, Leung K, Lui S, Mac-Moune L (2001) Grading of acute and chronic renal lesions in Henoch-Schönlein purpura. Mod Pathol 14:635–640. https://doi.org/10.1038/modpathol.3880364
Pohl M (2015) Henoch–Schönlein purpura nephritis. Pediatr Nephrol 30:245–252. https://doi.org/10.1007/s00467-014-2815-6
(2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555
Ginsberg J, Chang B, Matarese R, Garella S (1983) Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309:1543–1546. https://doi.org/10.1056/NEJM198312223092503
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO (2012) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150
Inker L, Schmid C, Tighiouart H, Feldmen H, Greene T, Kusek J, Manzi J, Van Lente F, Zhang Y, Coresh J, Levey A (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20–29. https://doi.org/10.1056/NEJMoa1114248
Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D (2002) Henoch-Schonlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13:1271–1278. https://doi.org/10.1097/01.ASN.0000013883.99976.22
Edström Halling S, Söderberg M, Berg U (2009) Treatment of severe Henoch–Schönlein and immunoglobulin A nephritis. A single center experience. Pediatr Nephrol 24:91–97. https://doi.org/10.1007/s00467-008-0990-z
Ho Kim C, Jin Lim B, Sung Bae Y, Eun Kwon Y, Heon Nam K, Sook Park K, Yeong An S, Mo Koo H, Mee Doh F, Jung Lee M, Jung OH, Yoo T, Kang S, Hun Choi K, Joo Jeong H, Han Seung H (2014) Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch–Schönlein purpura nephritis in adults. Mod Pathol 27:972–982. https://doi.org/10.1038/modpathol.2013.222
Levey A, Eckardt K, Tsukamoto Y, Levin A, Coresh J, Rossert J, Zeeuw D, Hostetter T, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100. https://doi.org/10.1111/j.1523-1755.2005.00365.x
Shin J, Park J, Shin Y, Kim J, Lee J, Kim P, Jeong H (2005) Can azathioprine and steroids alter the progression of severe Henoch-Schönlein nephritis in children? Pediatr Nephrol 20:1087–1092. https://doi.org/10.1007/s00467-005-1869-x
Kanai H, Sawanobori E, Kobayashi A, Matsishita K, Sugita K, Higashida K (2011) Early treatment with methylprednisolone pulse therapy combined with tonsillectomy for heavy proteinuric Henoch-Schönlein purpura nephritis in children. Nephron Extra 1:101–111. https://doi.org/10.1159/000333010
Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 12:238–243
Delbet J, Hogan J, Aoun B, Stoica I, Salomon R, Decramer S, Brocheriou I, Deschenes G, Ulinski T (2017) Clinical outcomes in children with Henoch–Schönlein purpura nephritis without crescents. Pediatr Nephrol 32:1193–1199. https://doi.org/10.1007/s00467-017-3604-9
Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S (2003) Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol Berl Ger 18:347–350. https://doi.org/10.1007/s00467-003-1094-4
Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N (1998) Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 12:244–248. https://doi.org/10.1007/s004670050447
Acknowledgments
We would like to thank Dan P. Goldstein and Marcia Voigt for their assistance with the collection of the data.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The Wake Forest School of Medicine Institutional Review Board approved the study.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jimenez, A., Chen, A., Lin, JJ. et al. Does MEST-C score predict outcomes in pediatric Henoch-Schönlein purpura nephritis?. Pediatr Nephrol 34, 2583–2589 (2019). https://doi.org/10.1007/s00467-019-04327-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-019-04327-2